Trefentanil

Trefentanil

File:Trefentanil.png
Clinical data
Synonyms	Trefentanil
Identifiers
IUPAC name N-[4-cyclohexyl-1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl] piperidin-4-yl]-N-(2-fluorophenyl)propanamide
CAS Number	120656-93-1
PubChem CID	60728
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C25H31FN6O2
Molar mass	466.551 g/mol

Trefentanil (A-3665) is an opioid analgesic that is an analogue of fentanyl and was developed in the early 1990s.

Trefentanil is most similar to short-acting fentanyl analogues such as alfentanil. In comparative studies, trefentanil was slightly more potent and shorter acting than alfentanil as an analgesic, but induced significantly more severe respiratory depression. For this reason trefentanil has not been adopted for clinical use, although it is still used in research.

Trefentanil has very similar effects to alfentanil, much like those of fentanyl itself but more potent and shorter lasting. Side effects of fentanyl analogues are similar to those of fentanyl, and include itching, nausea and potentially serious respiratory depression which can be life-threatening. The risk of respiratory depression is especially high with potent fentanyl analogues such as alfentanil and trefentanil, and these drugs pose a significant risk of death if used outside of a hospital setting with appropriate artificial breathing apparatus available.